Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 7 12 2018
medline: 21 10 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Several modifiable risk factors for cognitive decline have been identified, but whether differences by gender and educational level exist is unclear. The present study aims to clarify this by prospectively investigating the relationship between health and lifestyle factors and cognitive functioning in different subgroups defined by gender and educational level. 2,347 cognitive healthy individuals (mean age = 54.8, SD = 6.8, range: 41-71; 51.8% female; 26.2% low education) from the Doetinchem Cohort Study were examined for cognitive function at baseline, and at 5- and 10-year follow-up. Health- and lifestyle factors were captured by a poly-environmental risk score labelled 'LIfestyle for BRAin Health' (LIBRA). This score consists of 12 modifiable risk and protective factors for cognitive decline and dementia, with higher scores indicating greater risk (range: -2.7 to +12.7). Heterogeneity in associations between LIBRA and decline in verbal memory, cognitive flexibility, and mental speed between males and females and individuals with different levels of education were assessed in linear mixed models. Overall, higher LIBRA scores predicted faster decline in verbal memory, cognitive flexibility, and mental speed over 10 years. Higher LIBRA scores were further associated with increased risk for incident cognitive impairment (one-point increase in LIBRA: HR = 1.09, 1.04-1.14, p = 0.001). In general, these effects were similar across gender and educational level. A composite risk score comprising unhealthy lifestyle and relatively poor health in midlife is significantly associated with a worse course of cognition 10 years later. These associations were for the most part unrelated to gender or educational differences.

Sections du résumé

BACKGROUND
Several modifiable risk factors for cognitive decline have been identified, but whether differences by gender and educational level exist is unclear.
OBJECTIVE
The present study aims to clarify this by prospectively investigating the relationship between health and lifestyle factors and cognitive functioning in different subgroups defined by gender and educational level.
METHODS
2,347 cognitive healthy individuals (mean age = 54.8, SD = 6.8, range: 41-71; 51.8% female; 26.2% low education) from the Doetinchem Cohort Study were examined for cognitive function at baseline, and at 5- and 10-year follow-up. Health- and lifestyle factors were captured by a poly-environmental risk score labelled 'LIfestyle for BRAin Health' (LIBRA). This score consists of 12 modifiable risk and protective factors for cognitive decline and dementia, with higher scores indicating greater risk (range: -2.7 to +12.7). Heterogeneity in associations between LIBRA and decline in verbal memory, cognitive flexibility, and mental speed between males and females and individuals with different levels of education were assessed in linear mixed models.
RESULTS
Overall, higher LIBRA scores predicted faster decline in verbal memory, cognitive flexibility, and mental speed over 10 years. Higher LIBRA scores were further associated with increased risk for incident cognitive impairment (one-point increase in LIBRA: HR = 1.09, 1.04-1.14, p = 0.001). In general, these effects were similar across gender and educational level.
CONCLUSION
A composite risk score comprising unhealthy lifestyle and relatively poor health in midlife is significantly associated with a worse course of cognition 10 years later. These associations were for the most part unrelated to gender or educational differences.

Identifiants

pubmed: 30507570
pii: JAD180492
doi: 10.3233/JAD-180492
pmc: PMC6700651
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S31-S41

Références

Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
J Clin Exp Neuropsychol. 2003 Aug;25(5):625-33
pubmed: 12815500
BMJ. 2005 Apr 30;330(7498):991
pubmed: 15820966
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Psychol Med. 2006 Apr;36(4):441-54
pubmed: 16207391
Gend Med. 2007 Jun;4(2):120-9
pubmed: 17707846
Acta Psychiatr Scand. 2007 Oct;116(4):299-307
pubmed: 17803760
Int J Epidemiol. 2008 Dec;37(6):1236-41
pubmed: 18238821
Ann Intern Med. 2010 Aug 3;153(3):182-93
pubmed: 20547887
Br J Nutr. 2011 Sep;106(5):752-61
pubmed: 21477405
Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):289-304
pubmed: 21750453
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):335-43
pubmed: 22156756
Psychiatry Res. 2012 Mar 30;196(1):90-5
pubmed: 22390831
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Alzheimers Dement. 2013 Jan;9(1):1-11.e3
pubmed: 23305821
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Int J Geriatr Psychiatry. 2015 Mar;30(3):234-46
pubmed: 25504093
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
BMJ Open. 2016 Jan 04;6(1):e008565
pubmed: 26729377
J Am Heart Assoc. 2016 Jan 13;5(1):null
pubmed: 26764411
N Engl J Med. 2016 Feb 11;374(6):523-32
pubmed: 26863354
Alzheimers Dement. 2016 Mar;12(3):216-24
pubmed: 26874595
Psychiatry Investig. 2016 Sep;13(5):473-479
pubmed: 27757124
JAMA Intern Med. 2017 Jan 1;177(1):51-58
pubmed: 27893041
Pilot Feasibility Stud. 2015 Nov 17;1:40
pubmed: 27965818
Int J Geriatr Psychiatry. 2018 Jan;33(1):167-175
pubmed: 28247500
J Alzheimers Dis. 2017;58(2):537-547
pubmed: 28453475
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Neurology. 2017 Oct 31;89(18):1886-1893
pubmed: 28978656
Int J Epidemiol. 2017 Dec 1;46(6):1751-1751g
pubmed: 29040549
J Alzheimers Dis. 2018;62(1):373-384
pubmed: 29439337
Int J Epidemiol. 1997;26 Suppl 1:S37-48
pubmed: 9126532
Int J Epidemiol. 1997;26 Suppl 1:S49-58
pubmed: 9126533
Int J Epidemiol. 1997;26 Suppl 1:S181-9
pubmed: 9126546
Arch Gen Psychiatry. 1998 Sep;55(9):809-15
pubmed: 9736007
Neurology. 1999 Jan 1;52(1):78-84
pubmed: 9921852

Auteurs

Kay Deckers (K)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Astrid Nooyens (A)

Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Martin van Boxtel (M)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Frans Verhey (F)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Monique Verschuren (M)

Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.

Sebastian Köhler (S)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH